The fund was located in North America if to be more exact in United States. The main department of described Corporate Investor is located in the Westport.
The standard case for the fund is to invest in rounds with 3 partakers. Despite the JHK Investments, startups are often financed by Boston Financial & Equity Corporation, Bioventures Investors. The meaningful sponsors for the fund in investment in the same round are VantagePoint Capital Partners, IDP Industrial Development Partners, Boston Financial & Equity Corporation. In the next rounds fund is usually obtained by VantagePoint Capital Partners, REV, Peacock Equity.
Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Healthline Media, Angiolink Corporation. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. We can highlight the next thriving fund investment areas, such as Search Engine, Consumer.
The usual things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 deals per year. The top amount of exits for fund were in 2019. The important activity for fund was in 2000.
Related Funds
Funds with similar focus
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Angiolink Corporation | $13M | 10 Sep 2003 | Taunton, Massachusetts, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Angiolink Corporation | $13M | 10 Sep 2003 | Taunton, Massachusetts, United States |